Preliminary testing of a prespecified liability architecture for autism: theory-guided pathogenetic triad models outperform strength-matched alternatives - Poll - MDSpire

Preliminary testing of a prespecified liability architecture for autism: theory-guided pathogenetic triad models outperform strength-matched alternatives

  • By

  • Darko Sarovic

  • July 6, 2026

  • 0 min

Share

Original Source(s)

Preliminary testing of a prespecified liability architecture for autism: theory-guided pathogenetic triad models outperform strength-matched alternatives

  • by Darko Sarovic

  • July 6, 2026

Related Content

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

The burden of care, parenting stress, and navigating welfare services: parents’ everyday experiences of young children with autism spectrum disorder

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.